Avantor Investor Conference Presentation Deck
Business model gives us access to
high-growth production applications
EARLY PHASE DISCOVERY/R&D
Extraordinary access to early-stage
pipelines
Scale and infrastructure to
collaborate and engage with customers
Customization capability via 11
strategically located regional
innovation centers
40%
OF REVENUE
in growing production applications¹
avantor™
1. FY19 estimate
SCALE-UP/
REGULATORY APPROVAL
Commitment to quality via
comprehensive systems, change
management and audit programs
Deep regulatory expertise with fully
compliant documentation systems,
785+ DMF applications
Biopharma
Medical
devices
PRODUCTION
ORGANIC GROWTH $
Ultra-high-purity products with up to
part-per-trillion impurity levels
Transparency and security of supply
via robust documentation and supply
chain protocols
GMP manufacturing on three continents
Semiconductor
production
Space-grade
silicones
39th Annual J.P. Morgan Healthcare Conference
12View entire presentation